[Prevention strategy of beta-cell failure in ICA-positive NIDDM].
Kobayashi
T
T
Department of Endocrinology and Metabolism, Toranomon Hospital.
D000818:Animals; D001323:Autoantibodies / Q000032:analysis; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000209:etiology / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000276:immunology; D018450:Disease Progression; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*; D007515:Islets of Langerhans / Q000276:immunology*; D013997:Time Factors
D001323:Autoantibodies; D007004:Hypoglycemic Agents; D007328:Insulin